Global Genomic Biomarkers Market Size, Status and Forecast 2026


Report ID : RNR-228427 Category : Biotechnology Published Date : 2019
Publisher : S&P Consulting Pages : 91 Format : PDF
In 2017, the global Genomic Biomarkers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.
This report focuses on the global Genomic Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genomic Biomarkers development in United States, Europe and China.

The key players covered in this study

    Thermo Fisher Scientific

    F. Hoffmann-La Roche

    Aepodia

    Myriad Genetics

    Eurofins Scientific

    QIAGEN

    Bio-Rad Laboratories

    Genomic Health

    Liquid Genomics

    Epigenomics

    AROS Applied Biotechnology A/S

Market segment by Type, the product can be split into

    Oncology

    Cardiovascular diseases

    Neurological diseases

    Others

Market segment by Application, split into

    Diagnostic and research laboratories

    Hospitals

    Others

Market segment by Regions/Countries, this report covers

    United States

    Europe

    China

    Japan

    Southeast Asia

    India

    Central & South America

The study objectives of this report are:

    To analyze global Genomic Biomarkers status, future forecast, growth opportunity, key market and key players.

    To present the Genomic Biomarkers development in United States, Europe and China.

    To strategically profile the key players and comprehensively analyze their development plan and strategies.

    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Genomic Biomarkers are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2019

    Forecast Year 2019 to 2026

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Genomic Biomarkers Market Size Growth Rate by Type (2013-2026)
        1.4.2 Oncology
        1.4.3 Cardiovascular diseases
        1.4.4 Neurological diseases
        1.4.5 Others
    1.5 Market by Application
        1.5.1 Global Genomic Biomarkers Market Share by Application (2013-2026)
        1.5.2 Diagnostic and research laboratories
        1.5.3 Hospitals
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Genomic Biomarkers Market Size
    2.2 Genomic Biomarkers Growth Trends by Regions
        2.2.1 Genomic Biomarkers Market Size by Regions (2013-2026)
        2.2.2 Genomic Biomarkers Market Share by Regions (2013-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Genomic Biomarkers Market Size by Manufacturers
        3.1.1 Global Genomic Biomarkers Revenue by Manufacturers (2013-2019)
        3.1.2 Global Genomic Biomarkers Revenue Market Share by Manufacturers (2013-2019)
        3.1.3 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
    3.2 Genomic Biomarkers Key Players Head office and Area Served
    3.3 Key Players Genomic Biomarkers Product/Solution/Service
    3.4 Date of Enter into Genomic Biomarkers Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Genomic Biomarkers Market Size by Type (2013-2019)
    4.2 Global Genomic Biomarkers Market Size by Application (2013-2019)
5 United States
    5.1 United States Genomic Biomarkers Market Size (2013-2019)
    5.2 Genomic Biomarkers Key Players in United States
    5.3 United States Genomic Biomarkers Market Size by Type
    5.4 United States Genomic Biomarkers Market Size by Application
6 Europe
    6.1 Europe Genomic Biomarkers Market Size (2013-2019)
    6.2 Genomic Biomarkers Key Players in Europe
    6.3 Europe Genomic Biomarkers Market Size by Type
    6.4 Europe Genomic Biomarkers Market Size by Application
7 China
    7.1 China Genomic Biomarkers Market Size (2013-2019)
    7.2 Genomic Biomarkers Key Players in China
    7.3 China Genomic Biomarkers Market Size by Type
    7.4 China Genomic Biomarkers Market Size by Application
8 Japan
    8.1 Japan Genomic Biomarkers Market Size (2013-2019)
    8.2 Genomic Biomarkers Key Players in Japan
    8.3 Japan Genomic Biomarkers Market Size by Type
    8.4 Japan Genomic Biomarkers Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Genomic Biomarkers Market Size (2013-2019)
    9.2 Genomic Biomarkers Key Players in Southeast Asia
    9.3 Southeast Asia Genomic Biomarkers Market Size by Type
    9.4 Southeast Asia Genomic Biomarkers Market Size by Application
10 India
    10.1 India Genomic Biomarkers Market Size (2013-2019)
    10.2 Genomic Biomarkers Key Players in India
    10.3 India Genomic Biomarkers Market Size by Type
    10.4 India Genomic Biomarkers Market Size by Application
11 Central & South America
    11.1 Central & South America Genomic Biomarkers Market Size (2013-2019)
    11.2 Genomic Biomarkers Key Players in Central & South America
    11.3 Central & South America Genomic Biomarkers Market Size by Type
    11.4 Central & South America Genomic Biomarkers Market Size by Application
12 International Players Profiles
    12.1 Thermo Fisher Scientific
        12.1.1 Thermo Fisher Scientific Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Genomic Biomarkers Introduction
        12.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2013-2019)
        12.1.5 Thermo Fisher Scientific Recent Development
    12.2 F. Hoffmann-La Roche
        12.2.1 F. Hoffmann-La Roche Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Genomic Biomarkers Introduction
        12.2.4 F. Hoffmann-La Roche Revenue in Genomic Biomarkers Business (2013-2019)
        12.2.5 F. Hoffmann-La Roche Recent Development
    12.3 Aepodia
        12.3.1 Aepodia Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Genomic Biomarkers Introduction
        12.3.4 Aepodia Revenue in Genomic Biomarkers Business (2013-2019)
        12.3.5 Aepodia Recent Development
    12.4 Myriad Genetics
        12.4.1 Myriad Genetics Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Genomic Biomarkers Introduction
        12.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2013-2019)
        12.4.5 Myriad Genetics Recent Development
    12.5 Eurofins Scientific
        12.5.1 Eurofins Scientific Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Genomic Biomarkers Introduction
        12.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2013-2019)
        12.5.5 Eurofins Scientific Recent Development
    12.6 QIAGEN
        12.6.1 QIAGEN Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Genomic Biomarkers Introduction
        12.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2013-2019)
        12.6.5 QIAGEN Recent Development
    12.7 Bio-Rad Laboratories
        12.7.1 Bio-Rad Laboratories Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Genomic Biomarkers Introduction
        12.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2013-2019)
        12.7.5 Bio-Rad Laboratories Recent Development
    12.8 Genomic Health
        12.8.1 Genomic Health Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Genomic Biomarkers Introduction
        12.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2013-2019)
        12.8.5 Genomic Health Recent Development
    12.9 Liquid Genomics
        12.9.1 Liquid Genomics Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Genomic Biomarkers Introduction
        12.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2013-2019)
        12.9.5 Liquid Genomics Recent Development
    12.10 Epigenomics
        12.10.1 Epigenomics Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Genomic Biomarkers Introduction
        12.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2013-2019)
        12.10.5 Epigenomics Recent Development
    12.11 AROS Applied Biotechnology A/S
13 Market Forecast 2019-2026
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2026)
    13.10 Market Size Forecast by Application (2019-2026)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details